SCTX Insider Buy: AH Bio Fund II Purchases $5M in Shares
Another insider at Scribe Therapeutics, Inc. (SCTX) has stepped into the open market with a sizable purchase. According to a Form 4 filed with the SEC, AH Bio Fund II, L.P. bought 333,333 shares of the gene-editing biotech on July 27, 2026, paying $15.00 per share for a total outlay of $4,999,995.00. The transaction is … Read more